CAS 70310-73-5

(-)-Eseroline fumarate

CAS : 70310-73-5

(-)-Eseroline fumarate, a Physostigmine metabolite and AChE inhibitor, triggers cancer cell LDH release and neuronal cell death.

Formule : C₁₇H₂₂N₂O₅

Couleur et forme : Solid

Masse moléculaire : 334.37

Ref: TM-T73930

(-)-Eseroline Fumarate Salt

Produit contrôlé

CAS : 70310-73-5

Applications (-)-Eseroline Fumarate Salt is a metabolite of physostigmine, displaying both anti-acetylcholinesterase and opiate agonist activities.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Bartolini, Alessandro., Recent Pat CNS Drug Discov., 6, 119 (2011);

Formule : C₁₃H₁₈N₂O·(C₄H₄O₄)

Couleur et forme : Light Brown

Masse moléculaire : 218.29 + (116.07)

Ref: TR-E889163

(-)-Eseroline fumarate

CAS : 70310-73-5

(-)-Eseroline fumarate (Eseroline) is an acetylcholinesterase inhibitor that has been shown to have antinociceptive and depressant effects in mice. It also inhibits mitochondrial functions, but the exact mechanism of action is unknown. (-)-Eseroline fumarate has been shown to have a pharmacodynamic effect on human serum, inhibiting the formation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and increasing the level of cholesterol. Eseroline has also been shown to inhibit the growth of human breast cancer cells in culture by disrupting mitochondrial function and inhibiting acetylcholine synthesis. The biological properties of (-)-Eseroline are similar to those of eseroline, with one exception: eseroline does not exhibit any cholinergic activity.

Formule : C₁₃H₁₈N₂O·xC₄H₄O₄

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 334.4 g/mol

Ref: 3D-VCA31073